Drugs.com - Pharma Industry News

Hydroxyurea Has Sustained Clinical Benefits in Children With Sickle Cell Anemia

TUESDAY, April 29, 2025 -- For children with sickle cell anemia (SCA), hydroxyurea has sustained clinical benefits in terms of reducing emergency department visits and hospital days, according to a study published online April 16 in Blood...

Apr 29, 2025 - 18:55
 0
Hydroxyurea Has Sustained Clinical Benefits in Children With Sickle Cell Anemia
TUESDAY, April 29, 2025 -- For children with sickle cell anemia (SCA), hydroxyurea has sustained clinical benefits in terms of reducing emergency department visits and hospital days, according to a study published online April 16 in Blood...
Read More

Tags:

Previous Article

Intensive BP Reduction Effective for Lowering All-Cause Dementia Risk

Next Article

Artificial intelligence offers an array of benefits for beverage-makers

Related Posts

Early Combination of Lipid-Lowering Therapy Beneficial After Myocardial Infarction

Early Combination of Lipid-Lowering Therapy Beneficial ...

Apr 28, 2025  0

2019 to 2023 Saw Increase in Prevalence of Psilocybin Use in the United States

2019 to 2023 Saw Increase in Prevalence of Psilocybin U...

Apr 29, 2025  0

Low-to-Moderate Agreement Seen for Diagnosing Breast Cancer-Related Lymphedema

Low-to-Moderate Agreement Seen for Diagnosing Breast Ca...

Apr 24, 2025  0